Identity
- Security key
- 21419
- Ticker
- SCTX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2026-07-24
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- SCTX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $434,069,521.86
- Shares outstanding (class)
- —
- Shares outstanding (weighted)
- 18,864,386
- SIC
- —
- Employees
- —
- Location
- —
- Homepage
- https://www.scribetx.com
- Description
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Market cap and share counts drift.